Private Equity Firms Buying Manufacturing in 2026: 24 Named Platforms, AUM, Fund Vintages, and Target EBITDA Ranges

U.S. manufacturing M&A in 2026 is dominated by named PE platforms with explicit industrial or sub-vertical mandates. Below the mega-fund tier, 20+ middle-market PE firms have raised dedicated industrial funds in the $1B-$5B range over the past 36 months. Above the mega-fund tier, KKR, Carlyle, Bain Capital, and Onex Partners have run industrial verticals for 15-25 years. Plus a tier of sub-vertical specialists (aerospace, medical device, industrial chemicals, consumer/industrial) that compete aggressively within their domain. The buyer pool is structurally deep — the question for sellers is identifying which named platforms actually have a thesis for your business.

This guide covers 24+ named PE firms actively deploying capital into U.S. manufacturing in 2026. We’ll walk through generalist industrial platforms (Audax Industrial, GenNx360 Capital, Trive Capital, Sterling Group, Wynnchurch Capital, Cortec Group, Industrial Growth Partners, Mason Wells, Pfingsten Partners, AEA Investors, Genstar Capital, Pamlico Capital), sub-vertical specialists (AE Industrial Partners and Liberty Hall Capital for aerospace, Linden Capital Partners and Patient Square Capital and LaSalle Capital for medical device, Arsenal Capital Partners for industrial chemicals, Wind Point Partners for consumer/industrial), and mega-fund industrial verticals (KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries). For each: AUM, fund vintage, target EBITDA range, sub-vertical focus, and deal structure norms where verifiable.

The framework draws on direct work with 76+ active U.S. lower middle market buyers, of which 38 maintain explicit manufacturing or industrial mandates. We’re a buy-side partner. The buyers pay us when a deal closes — not you. That includes named industrial PE platforms with $250M-$5B+ funds, add-on programs at PE-backed manufacturing platforms, sub-vertical specialists, and mega-fund industrial groups. The point of this article isn’t to convince you to sell — it’s to give you a verified, named-platform overview of who is deploying capital into U.S. manufacturing in 2026 and at what scale.

One realistic note before you start. AUM figures cited below are approximate, drawn from public PE firm filings, fund-formation databases, press releases, and industry trade publications. Fund vintages and target EBITDA ranges are general guidelines; each platform’s actual deployment varies deal-by-deal. Treat the numbers as directional rather than precise — the value of this guide is the named entity coverage and the sub-vertical specialization framework, not the exact AUM rounding.

“There is no single “industrial PE firm.” Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch Capital, and Cortec Group are all generalist industrial platforms but they have materially different sub-vertical preferences, EBITDA ranges, deal structures, and post-close operating playbooks. AE Industrial Partners and Liberty Hall Capital won’t look at non-aerospace platforms. Linden Capital Partners and Patient Square Capital won’t look at non-healthcare platforms. The right outreach matches your sub-vertical to the platforms that actually have a thesis for your business — the wrong outreach wastes 6-9 months and leaves multiple on the table.”

Key Takeaways

• Generalist industrial PE platforms targeting $5M-$50M EBITDA at 6-9x: Audax Industrial (~$43B AUM), Genstar Capital ($50B+), AEA Investors ($18B+), Trive Capital (~$5B), Sterling Group ($5B+), Wynnchurch Capital (~$5B), Cortec Group ($2B+), GenNx360 Capital (~$1.5B), IGP, Mason Wells, Pfingsten Partners, Pamlico Capital ($3B+).
• Sub-vertical specialists adding 1-3x EBITDA of multiple expansion: AE Industrial Partners (~$5B, aerospace), Liberty Hall Capital (aerospace), Linden Capital Partners ($8B+, medical device), Patient Square Capital (~$10B, medical device), LaSalle Capital (medical device), Arsenal Capital Partners ($8B+, industrial chemicals), Wind Point Partners ($3B+, consumer/industrial).
• Mega-fund industrial verticals targeting $20M+ EBITDA at 8-12x: KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries.
• Add-on programs at all platforms target $1M-$5M EBITDA at 4-6x EBITDA — the realistic entry point for sub-LMM manufacturing sellers wanting PE access without standalone-platform requirements.
• Deal structure norms: cash + 20-30% rollover equity + 12-24 month earnout for platforms; cash + 10-20% rollover + retention earnout for add-ons. Earnouts typically tied to EBITDA performance, customer retention, or key-employee retention.
• Industrial PE dry powder has risen to record levels through 2024-2025 fund vintages, creating sustained bid for $5M+ EBITDA manufacturing platforms with sub-vertical specialization or growth runway.

How industrial PE platforms are organized: generalist, specialist, and mega-fund tiers

U.S. industrial-focused PE deploys across three tiers with materially different mandate scope and capital availability. Generalist industrial platforms (Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch Capital, Cortec Group, IGP, Mason Wells, Pfingsten, AEA, Genstar, Pamlico) have broad mandates across industrial services, manufacturing, and value-added distribution. Sub-vertical specialists (AE Industrial Partners, Liberty Hall Capital, Linden Capital Partners, Patient Square Capital, Arsenal Capital, Wind Point Partners) restrict to a single end-market (aerospace, medical device, industrial chemicals, consumer/industrial) but go deeper on operational expertise. Mega-fund industrial verticals (KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries) deploy from larger funds with broader mandates and typically enter at $20M+ EBITDA platform scale.

What this means for sellers. If your business has a clear sub-vertical (aerospace, medical device, defense, semiconductor, industrial chemicals, food and beverage manufacturing), you should reach the relevant specialist alongside generalists. Sub-vertical specialists pay 1-3x EBITDA more for businesses in their domain than generalists do because their LP capital is committed to the sub-vertical and they have operating expertise, customer relationships, and integration capability that generalists don’t. If your business is genuinely cross-vertical, generalist platforms are the realistic primary pool.

Add-on programs span all three tiers. Every named platform below runs an active add-on (bolt-on) acquisition program targeting $1M-$5M EBITDA businesses to bolt onto existing portfolio companies. Add-ons price at 4-6x EBITDA — lower than platform multiples because the bolt-on integrates into existing platform infrastructure, doesn’t need standalone management, and benefits from immediate multiple arbitrage at the platform’s exit. Sellers below $5M EBITDA should focus outreach on add-on programs rather than platform investments.

Generalist industrial PE platforms: 12 named firms

Audax Industrial / Audax Group (~$43B AUM, Boston). One of the largest middle-market industrial-focused PE platforms in North America. Industrial vertical targets $5M-$50M+ EBITDA across industrial services, manufacturing, value-added distribution, and infrastructure. Active across HVAC, plumbing, electrical, industrial services, machine shops, and contract manufacturing. Active add-on program at portfolio companies. Multiple recent fund vintages with billions deployed into industrial businesses.

Genstar Capital ($50B+ AUM, San Francisco). Diversified middle-market PE with multiple verticals including industrial. Industrial vertical targets $10M+ EBITDA. Active across specialty manufacturing, industrial services, and value-added distribution. Recent fund vintages have deployed billions into industrial platforms with clear sub-vertical specialization.

AEA Investors ($18B+ AUM, NYC). Long-tenured middle-market PE with industrial and value-added services focus. Targets $10M+ EBITDA platforms. Active across specialty manufacturing, value-added distribution, and industrial services. Multiple closed funds in the $1.5B-$3B range deploying into manufacturing.

Trive Capital (~$5B AUM, Dallas). Middle-market industrial-focused PE. Targets $5M-$30M EBITDA across industrial services, manufacturing, and consumer-adjacent industrial. Active in Texas-headquartered platforms but national mandate. Multiple recent fund vintages with industrial deployment.

Sterling Group ($5B+ AUM, Houston). One of the longest-tenured industrial-only PE firms in North America. Targets $10M+ EBITDA across industrial manufacturing, distribution, and services. Operating-intensive value creation playbook with deep industrial expertise. Active across machine shops, specialty manufacturing, and industrial distribution.

Wynnchurch Capital (~$5B AUM, Chicago). Middle-market value-investing industrial-focused PE. Targets $5M-$30M EBITDA across industrial manufacturing, services, and distribution. Active in turnaround and value-investing situations as well as core platform investments.

Cortec Group ($2B+ AUM, NYC). Middle-market PE with industrial and consumer focus. Targets $5M-$25M EBITDA across specialty manufacturing, industrial services, and consumer-adjacent industrial. Multiple recent fund vintages with industrial deployment.

GenNx360 Capital Partners (~$1.5B AUM, NYC). Middle-market industrial-focused PE. Targets $5M-$30M EBITDA across industrial services, manufacturing, and value-added distribution. Active across machine shops, contract manufacturing, and specialty industrial. Multiple closed funds with industrial deployment.

Industrial Growth Partners / IGP (San Francisco). Dedicated industrial-only PE firm. Targets $5M-$30M EBITDA across industrial manufacturing, services, and value-added distribution. Multiple closed funds with industrial deployment. Operating-intensive value creation playbook.

Mason Wells (Milwaukee). Midwestern industrial-focused PE. Targets $3M-$25M EBITDA across industrial manufacturing, packaging, and consumer-adjacent industrial. Strong Midwest network and relationships. Multiple closed funds with industrial deployment.

Pfingsten Partners (Chicago). Operations-focused middle-market industrial PE. Targets $3M-$25M EBITDA across specialty manufacturing, industrial services, and value-added distribution. Operating-intensive value creation with deep industrial expertise.

Pamlico Capital ($3B+ AUM, Charlotte). Middle-market PE with industrial vertical. Targets $5M-$25M EBITDA across industrial services, manufacturing, and tech-enabled industrial. Multiple closed funds with industrial deployment.

Sub-vertical specialist PE firms: 7 named firms

AE Industrial Partners (~$5B AUM, Boca Raton FL). One of the most active dedicated aerospace and defense PE firms in North America. Targets $5M-$100M+ EBITDA across aerospace, defense, space, and government services manufacturing. Particularly active in AS9100-certified, ITAR-registered, NADCAP-accredited precision manufacturing. Major customer relationships across Tier 1 aerospace OEMs and defense primes. Multiples to portfolio companies typically 8-12x EBITDA in defense/aerospace specialty work.

Liberty Hall Capital Partners (NYC). Aerospace and aviation-focused middle-market PE. Targets $5M-$50M EBITDA across aerospace structures, components, MRO, and aftermarket services. AS9100-certified and ITAR-registered platforms preferred. Active alongside AE Industrial Partners as the two leading dedicated aerospace PE firms.

Linden Capital Partners ($8B+ AUM, Chicago). Healthcare and medical-device-focused middle-market PE. Targets $10M+ EBITDA across medical device manufacturing (ISO 13485 + FDA registered), healthcare services, and life sciences. Multiple closed funds in $1B-$3B range with medical-device deployment. Multiples to medical-device manufacturers typically 8-12x EBITDA.

Patient Square Capital (~$10B AUM, Menlo Park CA). Healthcare-dedicated PE platform with significant medical-device manufacturing exposure. Targets $20M+ EBITDA in medical device, life sciences tools, and healthcare services. Recent fund vintages have deployed billions into medical device with FDA registration and ISO 13485 quality systems.

LaSalle Capital (Chicago). Lower-middle-market healthcare and consumer-focused PE. Targets $3M-$15M EBITDA in medical device, healthcare services, and specialty consumer products. Particularly active in medical-device contract manufacturing and specialty packaging.

Arsenal Capital Partners ($8B+ AUM, NYC). Industrial chemicals and specialty materials-focused PE. Targets $10M+ EBITDA across specialty chemicals, advanced materials, industrial coatings, and chemical manufacturing. Multiple closed funds with deep specialty-chemicals deployment. Active across pharma services and specialty industrial verticals.

Wind Point Partners ($3B+ AUM, Chicago). Diversified middle-market PE with consumer and industrial focus. Targets $5M-$30M EBITDA across consumer-adjacent industrial manufacturing, packaging, and specialty consumer products. Strong consumer goods + industrial diversified deployment.

Mega-fund industrial verticals: KKR, Carlyle, Bain Capital, Onex, Bromford

Mega-fund industrial verticals operate at $20M+ EBITDA platform scale. Each of the major U.S. mega-fund PE firms runs an industrial vertical with dedicated investment professionals, sector-specific deal flow, and operating-partner networks. These groups typically enter at $20M+ EBITDA platforms but will pursue smaller add-ons through portfolio companies. Multiples paid for differentiated mega-fund-quality platforms typically reach 8-12x EBITDA, sometimes higher for highly defensible niche businesses.

KKR Industrials. KKR’s industrials team deploys from KKR Americas Fund vintages with dedicated industrial sector coverage. Targets $20M+ EBITDA platforms across industrial manufacturing, services, infrastructure, and value-added distribution. Particularly active in industrials with structural growth tailwinds (semiconductor, defense, infrastructure, energy transition).

Carlyle Industrials. Carlyle’s industrials team deploys across U.S. and global industrial manufacturing, aerospace, and defense. Targets $25M+ EBITDA. Long-tenured industrial deployment across multiple fund vintages with global capability.

Bain Capital Industrials. Bain Capital’s industrials team deploys across industrial manufacturing, technology-enabled industrial, and specialty manufacturing. Targets $20M+ EBITDA. Particularly active in industrials with software/data layers and recurring service revenue.

Onex Partners Industrials. Onex’s industrial vertical deploys across U.S. industrial manufacturing and services. Targets $20M+ EBITDA across industrial services, specialty manufacturing, and value-added distribution. Multiple closed funds with industrial deployment.

Bromford Industries. Industrial-focused investment platform with manufacturing portfolio. Targets industrial manufacturing platforms with growth thesis. Active in specialty industrial verticals and U.S. middle-market manufacturing platforms.

How to interpret platform AUM, fund vintage, and target EBITDA

AUM is a directional indicator of capital availability, not a precise predictor of any individual deal. A $5B AUM industrial platform doesn’t mean they can deploy $5B into a single deal — it means they have multiple closed funds with cumulative committed capital around that level, deployed across 10-30 portfolio companies per fund vintage with typical platform investments of $50M-$300M of equity per deal. Larger AUM correlates with larger target EBITDA and typically more capacity for follow-on add-ons, but doesn’t guarantee they’ll bid on your specific business. For a deeper look, see our guide on why pe buying hvac companies. For a deeper look, see our guide on operational due diligence private equity.

Fund vintage matters because deployment cadence varies by year. PE funds typically deploy 60-75% of committed capital in years 2-4 after fund close, with the remainder deployed for follow-on add-ons in years 5-7. A platform with a recently-closed fund (vintage 2024-2025) is in active deployment mode and aggressive on new platforms. A platform with an older fund (vintage 2020-2021) may be focused on follow-on add-ons rather than new platforms. The most active 2026 deployment is at platforms with fund vintages from late 2023 through 2025.

Target EBITDA range is a soft guide, not a hard floor or ceiling. When a platform says they target “$5M-$30M EBITDA,” that’s their preferred deployment range for new platform investments. They’ll occasionally do bolt-ons below the floor and platform-of-platform deals above the ceiling for strategic reasons. Below the floor, you’re realistically pursuing add-on programs rather than platform investments. Above the ceiling, you’re realistically pursuing larger platforms or mega-fund verticals.

Sub-vertical specialization is the most important match criterion. Audax Industrial may be larger than Liberty Hall Capital by AUM, but if your business is AS9100-certified aerospace precision machining, Liberty Hall Capital is more likely to bid aggressively because they have the operating expertise, customer relationships, and integration capability for your sub-vertical. AUM matters less than mandate fit. Match sub-vertical first, EBITDA size second, AUM third.

Multiple ranges by platform tier and sub-vertical specialization

Generalist industrial PE platforms typically pay 6-9x TEV/EBITDA for platform investments. Specifically: $5M-$10M EBITDA platforms typically clear 6-7x. $10M-$20M EBITDA: 7-8x. $20M-$50M EBITDA with strong management depth and growth runway: 8-9x. Sub-vertical specialization, certifications, and customer-base diversification all push into the higher end of these ranges.

Sub-vertical specialists pay 1-3x EBITDA more than generalists in their domain. AE Industrial Partners and Liberty Hall Capital pay 7-10x for AS9100/ITAR aerospace platforms. Linden Capital Partners and Patient Square Capital pay 8-12x for ISO 13485 + FDA registered medical-device platforms. Arsenal Capital Partners pays 7-10x for specialty industrial chemicals. Wind Point Partners pays 6-9x for consumer/industrial. The premium reflects LP capital commitment to the sub-vertical, operating expertise, and strategic fit.

Mega-fund industrial verticals pay 8-12x for differentiated platforms. KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, and Bromford Industries pay premium multiples for $20M+ EBITDA platforms with clear competitive moats — typically 8-12x EBITDA. Highly defensible niche manufacturing platforms (semiconductor capital equipment, AS9100/ITAR/NADCAP defense aerospace, ISO 13485 medical device) can clear 12-15x EBITDA from mega-fund buyers in competitive auctions.

Add-on multiples are 1-2x lower than platform multiples. Add-on programs at all platforms pay 4-6x EBITDA for $1M-$5M EBITDA bolt-ons. The lower multiple reflects: (1) bolt-ons don’t need standalone management; (2) integration cost is real and absorbed by the platform; (3) bolt-ons benefit from immediate multiple arbitrage at the platform’s exit (a 5x add-on rolled into a 9x platform exit captures 4x of immediate arbitrage).

Deal structure norms across named PE platforms

Industrial PE platform deals typically structure as cash + rollover equity + earnout. Cash at close: 60-75% of TEV. Rollover equity into the platform: 15-30% of TEV (negotiable; some platforms encourage higher rollover for alignment, others prefer cash-heavy). Earnout: 5-25% of TEV tied to 12-24 month post-close performance milestones (EBITDA, revenue, customer retention, key-employee retention). For a deeper look, see our guide on how to sell an hvac business to private equity. For a deeper look, see our guide on selling an insulation business to private equity investors.

Why rollover equity matters at industrial PE platforms. Rolling 20-30% of equity into a platform like Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch Capital, or AEA Investors gives the seller continued exposure to upside as the platform scales. PE platforms typically exit in 3-5 years to a larger PE buyer (mega-fund industrial vertical) or public strategic acquirer at higher multiples. Sellers who roll equity often realize 1.5-2.5x of additional after-tax proceeds at platform exit. For a deeper look, see our guide on maximize your valuation sell to private equity.

Earnout norms in industrial PE deals. Earnouts are most often tied to TTM EBITDA performance over 12-24 months post-close, with thresholds at 90-95% of base-case projections. Earnouts can also tie to: customer retention (top 10 customers retained), key-employee retention (CFO, COO, head of operations stay 12-24 months), or revenue thresholds. Earnout realization rates in industrial PE deals have historically run 50-75% of full earnout potential, materially below the headline. Negotiate earnout terms carefully — particularly definitions and acceleration clauses.

Working capital adjustments and net working capital pegs. PE platforms scrutinize working capital aggressively. Net working capital peg (the target NWC level the seller delivers at close) is typically negotiated to a 12-month average or normalized level. Sellers often surprise themselves with how much working capital the buyer expects to receive at close — particularly DSO/DPO normalization and inventory levels. Pre-LOI, model the working capital adjustment carefully because it can move the headline price by $500K-$2M+ on a $20M deal.

How to identify which named PE platforms fit your business

Step 1: identify your sub-vertical and certifications. Map your business to: aerospace (AS9100, NADCAP, ITAR), medical device (ISO 13485, FDA registration), defense (ITAR, EAR), semiconductor (cleanroom, ISO 9001), industrial chemicals/specialty materials, machine shop / precision machining, metal fabrication / sheet metal, plastic injection molding, contract manufacturing, industrial automation, or consumer/industrial diversified.

Step 2: match sub-vertical to specialist platforms. Aerospace/defense: AE Industrial Partners, Liberty Hall Capital. Medical device: Linden Capital Partners, Patient Square Capital, LaSalle Capital. Industrial chemicals: Arsenal Capital Partners. Consumer/industrial: Wind Point Partners. If your sub-vertical isn’t covered by a specialist, focus on generalist platforms with relevant portfolio company experience.

Step 3: match EBITDA size to platform tier. $1M-$5M EBITDA: PE add-on programs at all named platforms. $5M-$30M EBITDA: generalist platforms (Audax Industrial, GenNx360, Trive, Sterling, Wynnchurch, Cortec, IGP, Mason Wells, Pfingsten, Pamlico) and sub-vertical specialists. $30M+ EBITDA: full generalist field plus mega-fund industrial (KKR, Carlyle, Bain Capital, Onex, Bromford).

Step 4: build targeted outreach list of 8-15 platforms. Mix specialists (if applicable), generalists with portfolio relevance, and one or two mega-fund verticals (if EBITDA size permits). Don’t cast too wide — outreach to 30+ platforms creates information leakage risk and signals desperation. 8-15 carefully selected, thesis-aligned platforms produces better outcomes than 30 generic outbound attempts.

Step 5: position the CIM for the targeted platform pool. PE platform CIMs emphasize TTM EBITDA, normalized adjusted EBITDA, sub-vertical positioning, customer concentration profile, management depth (CFO, COO presence), capex intensity (3-6% of revenue ideally), working capital efficiency (DSO/DPO/inventory turns), and 3-5 year growth thesis. Sub-vertical-specific CIMs lead with certifications and customer-base relevance to the specialist’s thesis.

2026 industrial PE deployment trends and structural drivers

Industrial PE dry powder is at record levels. Combined committed-but-unspent capital across industrial-focused PE platforms is estimated at $200B+ in 2026. Recent fund vintages (2023-2025) have raised record amounts at named platforms including Audax Industrial, Genstar Capital, AEA Investors, Trive Capital, Sterling Group, Wynnchurch Capital, AE Industrial Partners, Linden Capital Partners, Patient Square Capital, and Arsenal Capital Partners.

Reshoring/nearshoring is structural. Sustained reshoring announcements and supply-chain resilience priorities have driven LP allocation to U.S. industrial manufacturing. NAM’s Manufacturing Outlook Survey, AMT’s USMTO report, and ISM’s Manufacturing PMI all show sustained demand for U.S.-made components. Industrial PE platforms have responded with aggressive deployment into reshoring-positioned platforms.

Defense modernization drives aerospace/defense deployment. B-21 Raider production ramp, F-35 sustainment programs, NGAD development, missile defense expansion, and NATO partner rearmament drive sustained demand for AS9100, ITAR, NADCAP precision manufacturing. AE Industrial Partners, Liberty Hall Capital, and mega-fund industrial verticals have deployed billions into aerospace/defense in 2024-2026.

CHIPS Act drives semiconductor capital equipment deployment. Samsung Taylor, TI Sherman, Intel Ohio, GlobalFoundries Sherman, TSMC Arizona, Micron Boise, and other semiconductor fab buildouts drive demand for semiconductor capital equipment manufacturing. Specialty PE deployment into semiconductor equipment manufacturers has accelerated through 2024-2026 with multiples reaching 10-14x EBITDA for differentiated platforms.

Medical device deployment driven by aging population and reshoring. Aging U.S. and global population, FDA emphasis on domestic medical-device manufacturing, and supply-chain resilience priorities drive sustained medical-device deployment. Linden Capital Partners and Patient Square Capital have raised substantial dedicated medical-device funds with billions deployed into ISO 13485 + FDA registered manufacturers.

IIoT and Industry 4.0 drive software-margin manufacturing premium. Manufacturers with documented IIoT sensor deployment, MES/ERP integration, predictive maintenance programs, and digital factory capability draw premium multiples from generalist platforms (Audax Industrial, AEA Investors, Genstar Capital) and digitally-oriented strategics (Roper Technologies, Ametek). Software-like recurring revenue layered onto manufacturing platforms can push multiples 1-3x EBITDA above non-digital comparables.

Common mistakes manufacturing sellers make in PE platform outreach

Mistake 1: spraying outreach to 30+ platforms without sub-vertical filtering. Generic outreach to 30+ PE platforms signals naivety, creates information leakage risk, and dilutes the seriousness of any one conversation. Better approach: 8-15 carefully matched platforms with genuine thesis alignment to your sub-vertical and EBITDA size.

Mistake 2: pitching aerospace platforms without AS9100 / NADCAP / ITAR. AE Industrial Partners and Liberty Hall Capital won’t bid aggressively on uncertified manufacturing claiming aerospace exposure. Generic “we serve aerospace customers” positioning without the certifications doesn’t trigger specialist multiples. Either complete certification 18-36 months pre-sale or pitch to generalist platforms instead.

Mistake 3: pitching medical-device platforms without ISO 13485 / FDA registration. Linden Capital Partners, Patient Square Capital, and LaSalle Capital won’t bid aggressively on uncertified manufacturing claiming medical-device exposure. ISO 13485 + FDA registration is the entry requirement for specialist multiples. Generic “we make medical components” without certification gets you generalist multiples, not specialist multiples.

Mistake 4: presenting weak management depth to platform investors. PE platform investors require real management depth: CFO, COO, head of operations or sales as a minimum. If you’re a $5M+ EBITDA business and you’re still the de facto CFO and COO, platforms either pass or insist on 18-24 month management hires post-close (which compresses your multiple). 12-18 months pre-sale, hire a real CFO and operations manager.

Mistake 5: ignoring rollover equity opportunity. Sellers who refuse rollover equity reflexively and demand all-cash deals leave 1.5-2.5x of after-tax proceeds on the table. Rolling 20-30% into a platform like Audax Industrial, AEA Investors, Genstar Capital, or AE Industrial Partners typically returns 1.5-2.5x at platform exit in 3-5 years. Negotiate rollover terms carefully (anti-dilution, tag-along, drag-along, valuation methodology) but don’t reject reflexively.

Mistake 6: running a generic auction instead of matching to named platforms. A banker-led auction to 30 generic LMM PE firms is appropriate for $20M+ EBITDA platforms with broad mandates. For sub-$20M EBITDA, targeted outreach to 8-15 named platforms with sub-vertical fit produces materially better outcomes than generic auction processes. The named-platform approach captures specialist multiples that generic auctions miss.

How public-company strategic acquirers compete with PE platforms

Public-company strategic acquirers are increasingly competing with PE platforms for the same manufacturing acquisition targets. APi Group (NYSE: APG, ~$7B revenue), Comfort Systems USA (NYSE: FIX, ~$5B revenue), Watsco (NYSE: WSO, ~$7B revenue), Roper Technologies (NYSE: ROP, $6B+ revenue), HEICO (NYSE: HEI, ~$4B revenue), Atkore (NYSE: ATKR), Curtiss-Wright (NYSE: CW), TransDigm (NYSE: TDG), Harsco (NYSE: HSC), and Ametek (NYSE: AME) all run aggressive M&A programs that overlap with PE platform mandates. The competitive bidding dynamic between PE and public strategics creates seller-favorable dynamics in 2026 manufacturing M&A.

Why public consolidators sometimes outbid PE. Public strategics underwrite synergy-adjusted EBITDA against their existing platform infrastructure. HEICO can pay 9-11x EBITDA for an aerospace components business because their existing Tier 1 OEM relationships, certification infrastructure, and aftermarket distribution add 30-50% of synergy value within 12-24 months. Roper Technologies can pay 11-14x for niche industrial businesses with software-margin overlay because their portfolio of recurring-revenue niche industrial businesses creates strategic optionality. APi Group and Comfort Systems USA can pay 8-10x for industrial-services-adjacent manufacturing because of capacity utilization and customer cross-sell synergies.

When PE outbids public strategics. PE platforms outbid public strategics in scenarios where: (1) the seller wants rollover equity to participate in a 3-5 year exit upside (public strategics typically offer cash with smaller stock components, while PE platforms offer 20-30% rollover into the platform); (2) the public strategic isn’t already in the sub-vertical so the synergy thesis is weaker; (3) the seller wants continued operational control (PE platforms offer CEO continuity 2-4 years; public strategics typically integrate into existing corporate structure quickly); (4) the deal size is below the public strategic’s minimum threshold ($25M+ EBITDA for many large public consolidators).

How sellers should run parallel processes. For $5M+ EBITDA manufacturing platforms with potential strategic fit, run a parallel process with 8-15 PE platforms (mix of generalists and sub-vertical specialists) and 2-3 public-company strategic targets. The parallel approach maintains leverage, validates the market multiple, and gives the seller flexibility to choose between PE rollover-and-participate path versus strategic cash-and-exit path. Most sellers who accept the first reach-out leave 1-2x EBITDA on the table.

Industry associations as sourcing channels. NAM (National Association of Manufacturers), NTMA (National Tooling and Machining Association), AMT (Association for Manufacturing Technology), PMA (Precision Metalforming Association), MAPI (Manufacturers Alliance), Material Handling Institute, ABMA (American Bearing Manufacturers Association), and AHRI (Air-Conditioning, Heating & Refrigeration Institute) are the primary sourcing channels both for PE platform business development teams and for public-company strategic acquirers. Owners attending industry conferences, participating in association events, and maintaining membership profiles are systematically more visible to active acquirers than owners who don’t.

Manufacturing-specific underwriting frameworks each platform tier uses

Each platform tier underwrites manufacturing through a different lens with different priorities. Generalist PE platforms (Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch, Cortec, IGP, Mason Wells, Pfingsten, AEA, Genstar, Pamlico) underwrite for multiple arbitrage and 3-5 year exit. Sub-vertical specialists (AE Industrial Partners, Liberty Hall Capital, Linden Capital Partners, Patient Square Capital, LaSalle Capital, Arsenal Capital, Wind Point Partners) underwrite for sub-vertical fit and operational synergies with existing portfolio. Mega-fund industrial verticals (KKR, Carlyle, Bain Capital, Onex, Bromford Industries) underwrite for platform-of-platform thesis and exit pathway optionality. Public consolidators underwrite for synergy-adjusted EBITDA and customer/capacity overlap.

What generalist PE platforms scrutinize most heavily. TTM EBITDA quality (audited or reviewed financials, normalized adjusted EBITDA bridge with clear add-back rationale), customer concentration (top 5 under 50% of revenue ideally, top 1 under 30%), management depth (CFO, COO, head of operations or sales presence at $5M+ scale), capex intensity (3-6% of revenue ongoing capex preferred), working capital efficiency (DSO 45-60 days, DPO 45-60 days, inventory turns 4-8x annually), and 3-5 year growth thesis with quantifiable milestones. Generalist PE platforms typically pass on businesses with weak management depth, customer concentration above 40%, or capex intensity above 8%.

What sub-vertical specialists scrutinize most heavily. Sub-vertical certifications (AS9100 + NADCAP + ITAR for aerospace, ISO 13485 + FDA registration for medical device, ISO 9001 + ITAR for defense, specialty chemicals and materials credentials for Arsenal Capital), Tier 1 OEM qualified-supplier status (Boeing BAC, Lockheed Martin, Raytheon, GE Aviation, Northrop Grumman, Pratt & Whitney for aerospace; Medtronic, Stryker, Johnson & Johnson, Boston Scientific, Abbott, Becton Dickinson for medical device), long-tenure programs (5-15+ years on specific aircraft platforms, medical device families, or specialty chemical formulations), and integration potential with existing portfolio companies.

What mega-fund industrial verticals scrutinize most heavily. KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, and Bromford Industries underwrite for: $20M+ EBITDA scale, defensible competitive moats (technical, regulatory, customer-relationship, or scale-based), exit pathway optionality (multiple potential acquirers at exit including public consolidators and other PE), management team that can scale to $50M-$100M+ EBITDA, and platform-of-platform thesis (the platform itself can be a roll-up vehicle acquiring smaller bolt-ons under the mega-fund’s ownership). Mega-fund verticals typically pass on businesses without clear competitive moats or scaling potential.

What public consolidators scrutinize most heavily. Public consolidators (APi Group, Comfort Systems USA, Watsco, Roper Technologies, HEICO, Atkore, Curtiss-Wright, TransDigm, Harsco, Ametek) underwrite for synergy-adjusted EBITDA (standalone EBITDA + identified cost synergies + revenue synergies – dis-synergies), customer-base overlap (positive synergy or negative dis-synergy depending on situation), capacity utilization fit (does the acquired capacity solve their capacity constraint), capability gap-filling (does the acquired business have certifications, technical capability, or geographic presence the consolidator lacks), and integration risk (cultural, workforce, certification, customer-program continuity). Public consolidators typically pay above PE platform multiples when synergies are real and provable.

References and further reading

Verifiable PE firm sites, U.S. government sources, and industry association data backing the named-entity coverage above. AUM figures, fund vintages, and target ranges are drawn from public PE firm filings, Form ADV disclosures, fund-formation databases, press releases, industry trade publications, and the named firms’ own investor materials. The references section at the end lists verified URLs for further research.

Conclusion

The U.S. manufacturing PE buyer pool in 2026 is structurally deep but requires named-platform precision to capture full value. Generalist industrial platforms (Audax Industrial, GenNx360, Trive Capital, Sterling Group, Wynnchurch Capital, Cortec Group, Industrial Growth Partners, Mason Wells, Pfingsten Partners, AEA Investors, Genstar Capital, Pamlico Capital) target $5M-$30M EBITDA at 6-9x. Sub-vertical specialists (AE Industrial Partners and Liberty Hall Capital for aerospace, Linden Capital Partners and Patient Square Capital and LaSalle Capital for medical device, Arsenal Capital Partners for industrial chemicals, Wind Point Partners for consumer/industrial) add 1-3x EBITDA of multiple expansion in their domains. Mega-fund industrial verticals (KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries) target $20M+ EBITDA at 8-12x. Add-on programs at all platforms cover $1M-$5M EBITDA at 4-6x. Owners who succeed are the ones who match sub-vertical and EBITDA size to named platforms early, position certifications (AS9100, ISO 13485, NADCAP, ITAR) as competitive moats, hire real management depth (CFO, COO) 12-18 months pre-sale, and run targeted outreach to 8-15 thesis-aligned platforms rather than spraying 30+ generic LMM firms. The owners who do this work see 1-3x EBITDA better outcomes than the ones who go to market unprepared. And if you want to talk to someone who already knows the PE buyers personally instead of running a generic auction, we’re a buy-side partner — the buyers pay us, not you, no contract required.

Frequently Asked Questions

Which private equity firms are buying manufacturing in 2026?

Generalist industrial platforms: Audax Industrial (~$43B AUM), Genstar Capital ($50B+), AEA Investors ($18B+), Trive Capital (~$5B), Sterling Group ($5B+), Wynnchurch Capital (~$5B), Cortec Group ($2B+), GenNx360 Capital (~$1.5B), Industrial Growth Partners, Mason Wells, Pfingsten Partners, Pamlico Capital ($3B+). Sub-vertical specialists: AE Industrial Partners (~$5B, aerospace), Liberty Hall Capital (aerospace), Linden Capital Partners ($8B+, medical device), Patient Square Capital (~$10B, medical device), LaSalle Capital (medical device), Arsenal Capital Partners ($8B+, industrial chemicals), Wind Point Partners ($3B+, consumer/industrial). Mega-fund industrial verticals: KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, Bromford Industries.

What EBITDA size do industrial PE platforms target?

Generalist platforms typically target $5M-$30M EBITDA for new platform investments. Sub-vertical specialists target $5M-$50M with sub-vertical fit. Mega-fund industrial verticals target $20M+ EBITDA. Add-on programs at all platforms target $1M-$5M EBITDA bolt-ons to existing portfolio companies. Sub-$1M EBITDA realistically falls below the PE buyer pool and into the SBA-financed individual market.

What multiples does Audax Industrial pay for manufacturing platforms?

Audax Industrial pays generalist industrial PE multiples in the 6-9x TEV/EBITDA range for new platform investments at $5M-$30M EBITDA. Add-ons at Audax portfolio companies typically clear 4-6x EBITDA. Differentiated platforms with strong management, sub-vertical specialization, and growth runway can clear 8-9x. Audax is one of the most active middle-market industrial deployers in 2026.

Which PE firms specialize in aerospace manufacturing?

AE Industrial Partners (~$5B AUM, Boca Raton FL) and Liberty Hall Capital Partners (NYC) are the two leading dedicated aerospace and defense PE firms. Both target AS9100-certified, ITAR-registered, NADCAP-accredited precision manufacturing. Multiples in aerospace specialty work typically clear 7-10x EBITDA, materially above generalist multiples for the same earnings size. Mega-fund industrial verticals (KKR, Carlyle, Bain Capital) also deploy actively into $20M+ EBITDA aerospace platforms at 8-12x EBITDA.

Which PE firms specialize in medical device manufacturing?

Linden Capital Partners ($8B+ AUM, Chicago) and Patient Square Capital (~$10B AUM, Menlo Park CA) are the two leading dedicated healthcare/medical-device PE firms. LaSalle Capital (Chicago) covers lower-middle-market medical device. All three target ISO 13485 + FDA registered medical-device manufacturers. Multiples in specialty medical device clear 8-12x EBITDA, the highest sub-vertical band in manufacturing M&A.

How does Sterling Group differ from Audax Industrial?

Sterling Group ($5B+ AUM, Houston) is one of the longest-tenured dedicated industrial-only PE firms with operating-intensive value creation. Audax Industrial (~$43B AUM, Boston) has a broader middle-market PE platform with industrial as one of multiple verticals. Sterling typically targets $10M+ EBITDA industrial manufacturing/distribution/services with deep operating involvement. Audax targets $5M-$50M+ industrial across services and manufacturing with aggressive add-on programs at portfolio companies.

What’s the difference between a platform investment and an add-on?

A platform investment is a PE firm’s first acquisition into a sub-vertical — the foundation for a roll-up. Platforms target $5M-$30M EBITDA, get 6-9x multiples, and need standalone management. An add-on is a tuck-in to an existing platform — smaller ($1M-$5M EBITDA), lower multiples (4-6x), and the platform team integrates and operates the bolt-on. Add-ons close faster (60-120 days) because financing is in place at the platform level.

How much rollover equity should I expect with industrial PE platforms?

Industrial PE platforms typically want 20-30% rollover equity from sellers. Some platforms (Audax Industrial, AEA Investors, Genstar Capital) actively encourage higher rollover (30-40%) for alignment. Others (some mega-fund verticals) prefer cash-heavy with smaller rollover (15-20%). Sub-vertical specialists (AE Industrial Partners, Liberty Hall Capital, Linden Capital, Patient Square) often want substantial rollover (25-40%) because their thesis assumes seller continuity through platform scaling.

What’s industrial PE dry powder in 2026?

Combined committed-but-unspent capital across U.S. industrial-focused PE platforms is estimated at $200B+ in 2026. Recent fund vintages (2023-2025) have raised record amounts: Audax Industrial multi-billion-dollar fund vintages, Genstar Capital $50B+ AUM, AEA Investors $18B+, AE Industrial Partners ~$5B, Linden Capital Partners $8B+, Patient Square Capital ~$10B, Arsenal Capital Partners $8B+. Mega-fund industrial verticals at KKR, Carlyle, Bain Capital, Onex add additional billions of deployment capacity.

Should I run an auction or targeted outreach to PE platforms?

$20M+ EBITDA platforms with broad mandates: banker-led auction to 20-30 invited platforms is appropriate. $5M-$20M EBITDA: targeted outreach to 8-15 thesis-aligned platforms produces better outcomes than generic auction. Sub-$5M EBITDA: targeted outreach to PE add-on programs at sub-vertical-relevant platforms beats any auction approach. The named-platform approach captures specialist multiples that generic auctions miss.

What manufacturing certifications matter for PE platform multiples?

AS9100 (aerospace) +1-2x EBITDA from generalists, +1-3x from aerospace specialists (AE Industrial Partners, Liberty Hall Capital). ISO 13485 + FDA registration (medical device) +2-3x EBITDA, particularly from medical-device specialists (Linden Capital, Patient Square Capital, LaSalle Capital). NADCAP special-process accreditation +0.5-1x. ITAR registration (defense) +1-2x. Certifications widen the buyer pool to specialty platforms and unlock specialist multiples that generic platforms can’t match.

How do mega-fund industrial verticals (KKR, Carlyle, Bain Capital) compete with generalist platforms?

Mega-fund industrial verticals at KKR Industrials, Carlyle industrials, Bain Capital industrials, Onex Partners industrials, and Bromford Industries typically enter at $20M+ EBITDA platform scale and pay 8-12x EBITDA for differentiated platforms. They compete with the larger generalists (Audax Industrial, Genstar Capital, AEA Investors) on $20M-$50M EBITDA platforms but rarely overlap with smaller generalists (Cortec, GenNx360, Trive, Sterling, Wynnchurch, IGP, Mason Wells, Pfingsten, Pamlico) which focus below $20M EBITDA.

How is CT Acquisitions different from a sell-side broker or M&A advisor?

We’re a buy-side partner, not a sell-side broker. Sell-side brokers represent you and charge you 8-12% of the deal (often $300K-$1M+) plus monthly retainers, run a 9-12 month auction process, and require 12-month exclusivity. We work directly with 76+ buyers — 38 of them with active manufacturing/industrial mandates including the 24+ named PE platforms in this guide (generalists, sub-vertical specialists, mega-fund industrial verticals) — who pay us when a deal closes. You pay nothing. No retainer, no exclusivity, no contract until a buyer is at the closing table. We move faster (60-180 days from intro to close) because we already know which named platforms fit your manufacturing business by sub-vertical and EBITDA size rather than running a generic auction to find one.

Sources & References

All claims and figures in this analysis are sourced from the publicly available references below.

1. Audax Group — Industrial-focused PE firm with $43B+ AUM; publishes portfolio company list and sector strategy across industrial services, manufacturing, and value-added distribution.
2. Sterling Group — Houston-based industrial-only PE firm; publishes portfolio and investment criteria for industrial manufacturing platforms.
3. Wynnchurch Capital — Chicago-based middle-market value-investing industrial PE firm; publishes portfolio and investment criteria.
4. AE Industrial Partners — Aerospace and defense-focused PE firm; publishes portfolio across aerospace, defense, space, and government services manufacturing.
5. Linden Capital Partners — Healthcare and medical-device-focused middle-market PE firm; publishes portfolio across medical device manufacturing, healthcare services, and life sciences.
6. Genstar Capital — Diversified middle-market PE with industrial vertical; $50B+ AUM.
7. AEA Investors — Long-tenured middle-market PE with industrial and value-added services focus; $18B+ AUM.
8. Arsenal Capital Partners — Industrial chemicals and specialty materials-focused PE; $8B+ AUM.
9. U.S. Small Business Administration SOP 50 10 7 — Governs SBA 7(a) and 504 loan programs relevant to add-on acquisitions and search-funded manufacturing transactions.
10. National Association of Manufacturers (NAM) — Trade association representing 13,000+ U.S. manufacturers; publishes Manufacturing Outlook Survey documenting capex intentions, hiring plans, and supply-chain priorities.
11. Institute for Supply Management Manufacturing PMI — Monthly Manufacturing PMI tracking new orders, production, employment, and inventories — primary leading indicator of manufacturing demand.
12. Bureau of Economic Analysis — Industry GDP — Manufacturing share of U.S. GDP and value-added output by sub-sector.